Helping smokers practice quitting tobacco
Official title: A Mechanistic Test of Treatment Strategies to Foster Practice Quitting
Run by Rush University Medical Center · NCT05513872 · Data updated 2026-11-12
This study is testing a new way to help smokers practice quitting tobacco by trying short breaks from smoking without pressure, comparing it to regular counseling, to see which method helps them make more quit attempts over six months.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 780 (estimated) |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 24, 2023 |
| Main results expected | August 30, 2027 |
| Study ends | August 30, 2027 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT05513872 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who smoke at least five cigarettes daily and are not planning to quit in the next 30 days.
✕Probably not a fit
Patients who are daily users of vaping or electronic cigarettes or those with specific health contraindications for nicotine replacement therapy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to address tobacco use disorder by exploring a novel approach called practice quitting (PQ), which encourages smokers to attempt not smoking for short periods without the pressure of a permanent quit date. It will compare the effectiveness of PQ counseling against Motivational Interviewing (MI) counseling, alongside the provision of nicotine replacement therapy (NRT) samples. The study will involve 780 current smokers who are not planning to quit in the next 30 days, evaluating the impact of these interventions on the incidence of quit attempts over six months.
Why it matters
Potential benefit: If successful, this approach could significantly increase the number of smokers making quit attempts and ultimately lead to higher cessation rates.
How similar studies have gone: Previous studies have shown promise in using practice quitting as a strategy for smoking cessation, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Eligible participants will be males and females who: 1. are 18 years or older 2. report current daily cigarette smoking (≥ 5 cigarettes per day) 3. are not planning to quit in the next 30 days 4. are not currently engaged in smoking cessation treatment 5. are motivated to quit or engage in a non-cessation goal (i.e., reduce smoking, learn more about treatment options, and/ or try out skills to change smoking) in the next 6 months 6. are English speaking 7. reside in the continental United States 8. have access to a smartphone that can be used to complete study procedures Exclusion Criteria: Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications for NRT use if they: 1. are pregnant/breastfeeding 2. had recent cardiovascular trauma such as myocardial infarction 3. had a stroke within the past 3 months
Where it's running
-
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Amanda Mathew, PhD — Rush University Medical Center
- Study coordinator: Maritza Esqueda-Medina
- Email: on-deq@rush.edu
- Phone: 312-563-3702
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using an air quality monitor to encourage smoke-free homes for cancer patients
This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.
-
How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel
This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.
-
Tirzepatide for Smoking Cessation in people who smoke and are overweight or obese
This study tests whether tirzepatide can help adults who smoke quit and manage weight better than placebo when combined with usual smoking-cessation support.
-
Feasibility of a perinatal smoking and cannabis cessation program
This study tests a perinatal program to help pregnant people quit tobacco and cannabis and stay smoke-free after birth.
-
Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients
This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.
-
Telegram-based smoking-cessation support after heart attack
This trial tests whether a 6-month Telegram chatbot program helps people who had a heart attack quit smoking more often than standard care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.